Recent developments in the management of secondary hyperparathyroidism
- 1 March 2001
- journal article
- case report
- Published by Elsevier in Kidney International
- Vol. 59 (3) , 1187-1201
- https://doi.org/10.1046/j.1523-1755.2001.0590031187.x
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisNew England Journal of Medicine, 2000
- Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national studyAmerican Journal of Kidney Diseases, 1998
- Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitroJournal of Bone and Mineral Research, 1996
- Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.Journal of Clinical Investigation, 1996
- Pathogenesis of Secondary HyperparathyroidismAmerican Journal of Kidney Diseases, 1994
- Mechanisms underlying the regulation of parathyroid hormone secretion in vivo and in vitroCurrent Opinion in Nephrology and Hypertension, 1993
- Hyperphosphatemia: Its Consequences and Treatment in Patients With Chronic Renal DiseaseAmerican Journal of Kidney Diseases, 1992
- Conserved mechanism of negative gene regulation by extracellular calcium. Parathyroid hormone gene versus atrial natriuretic polypeptide gene.Journal of Clinical Investigation, 1992
- Oral and Parenteral Calcitriol for the Management of End-Stage Renal Disease1Published by S. Karger AG ,1990
- Reduced Binding of [3H]l,25-Dihydroxyvitamin D3in the Parathyroid Glands of Patients with Renal FailureNew England Journal of Medicine, 1987